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The mitochondrial protein AFG3L2 forms homo-oligomeric and hetero-oligomeric complexes with paraplegin
in the inner mitochondrial membrane, named m-AAA proteases. These complexes are in charge of quality
control of misfolded proteins and participate in the regulation of OPA1 proteolytic cleavage, required for
mitochondrial fusion. Mutations in AFG3L2 cause spinocerebellar ataxia type 28 and a complex neurodegen-
erative syndrome of childhood. In this study, we demonstrated that the loss of AFG3L2 in mouse embryonic
fibroblasts (MEFs) reduces mitochondrial Ca21 uptake capacity. This defect is neither a consequence of
global alteration in cellular Ca21 homeostasis nor of the reduced driving force for Ca21 internalization
within mitochondria, since cytosolic Ca21 transients and mitochondrial membrane potential remain unaffect-
ed. Moreover, experiments in permeabilized cells revealed unaltered mitochondrial Ca21 uptake speed in
Afg3l22/2 cells, indicating the presence of functional Ca21 uptake machinery. Our results show that the de-
fective Ca21 handling in Afg3l22/2 cells is caused by fragmentation of the mitochondrial network, secondary
to respiratory dysfunction and the consequent processing of OPA1. This leaves a number of mitochondria
devoid of connections to the ER and thus without Ca21 elevations, hampering the proper Ca21 diffusion
along the mitochondrial network. The recovery of mitochondrial fragmentation in Afg3l22/2 MEFs by overex-
pression of OPA1 rescues the impaired mitochondrial Ca21 buffering, but fails to restore respiration. By link-
ing mitochondrial morphology and Ca21 homeostasis, these findings shed new light in the molecular
mechanisms underlining neurodegeneration caused by AFG3L2 mutations.
INTRODUCTION
Mitochondria are interconnected dynamic organelles central to
energy production, fatty acid metabolism and Ca2+ buffering.
Dysfunction of mitochondria causes oxidative stress, per-
turbed cellular Ca2+ homeostasis and cell death and is
linked to aging and neurodegeneration.
Several surveillance mechanisms have evolved to prevent
the accumulation of dysfunctional mitochondria, such as the
continuous remodelling of the mitochondrial network and
mitophagy (1). At the organellar level, highly conserved pro-
teases conduct protein quality control (2). Among them,
m-AAA proteases belong to the AAA-protein superfamily
(ATPases associated with a variety of cellular activities) and
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are present as AFG3L2 homo-oligomers or
paraplegin-AFG3L2 hetero-oligomers in the inner mitochon-
drial membrane. The m-AAA complexes mediate the selective
degradation of non-assembled and damaged proteins (2) and
exert chaperone-like activity on respiratory chain complexes
(3–5). In addition, they perform proteolytic cleavage of sub-
strates, which are the nuclear-encoded subunit of mitochon-
drial ribosomes MrpL32 and the regulator of mitochondrial
fusion OPA1 (6,7). Both paraplegin and AFG3L2 have been
linked to neurodegenerative disorders: mutations in the
paraplegin-coding gene cause a recessive form of hereditary
spastic paraplegia (8), while heterozygous and homozygous
mutations in AFG3L2 have been associated to spinocerebellar
ataxia type 28 (SCA28) (9–11) and to a novel progressive
myoclonic epilepsy-ataxia-polyneuropathy syndrome of child-
hood, respectively (12). Whether these diverse diseases reflect
tissue-specific expression level of paraplegin and AFG3L2
(13) or different substrate specificity of the two proteases
remain to be clarified.
We provided evidence that Afg3l22/2 mice resemble
patients carrying homozygous mutations, showing a severe
neurological syndrome that leads to lethality at P16 (5). Ac-
cordingly, Afg3l2 haploinsufficient mice recapitulate most fea-
tures of SCA28 patients, displaying defects in motor
coordination and balance due to dark degeneration of Purkinje
cells (PC-DCD) (14). The latter is a phenomenon documented
in other SCAs as secondary to excitotoxicity and high levels of
intracellular Ca2+, which cause calpain-mediated cytoskeletal
breakdown (15,16). Peculiarly, in the SCA28 model, PC-DCD
originates from mitochondrial dysfunction, as demonstrated by
the fact that alterations in mitochondrial morphology and me-
tabolism precede PC degeneration (14).
We hypothesize that Afg3l2-depleted mitochondria have de-
fective Ca2+ buffering capacity, leading to dysregulation of
cytosolic Ca2+ homeostasis and finally to PC-DCD. Indeed,
compelling evidence in the literature points at the central
role of mitochondrial Ca2+ buffering in shaping the amplitude
and the spatio-temporal dimension of intracellular Ca2+ waves
(17,18). This is particularly crucial for neurons, and especially
for PCs, which uniquely receive glutamatergic afferents and
experience large and sudden Ca2+ influx (19).
Mitochondria take up Ca2+ rapidly from the cytoplasm
during agonist-induced Ca2+ signals, thanks to the strong
driving force ensured by the mitochondrial membrane poten-
tial (Dcm) via a low-affinity Ca
2+ channel of the inner mem-
brane (20). Impairment of mitochondrial Ca2+ buffering can
result from dysfunction of mitochondrial metabolism or from
functional defects of the mitochondrial Ca2+ uptake machin-
ery (20,21). Also, fragmentation of the mitochondrial
network has been shown to interrupt intramitochondrial
Ca2+ wave and to reduce mitochondrial Ca2+ uptake (22).
In this study, we investigated the mitochondrial Ca2+ hand-
ling capacity in Afg3l2- depleted fibroblasts. Our results dem-
onstrate that the loss of AFG3L2 reduces the average
mitochondrial Ca2+ uptake leaving Dcm and the Ca
2+
import machinery unaffected. The defective Ca2+ load is
caused by fragmentation of the mitochondrial network, due
to increased processing of OPA1, which reduces the volume
of individual organellar particles and disrupt the matrix con-
tinuity of the mitochondrial network.
RESULTS
Loss of Afg3l2 causes reduced mitochondrial Ca21 uptake
To examine the effect of the loss or haploinsufficiency of
Afg3l2 on mitochondrial Ca2+ buffering, we performed Ca2+
measurements on mouse embryonic fibroblasts (MEFs) by
employing aequorin chimeras targeted to mitochondria and
cytosol compartments (mtAEQmut and cytAEQ) (23). Cells
were challenged with bradykinin, which leads to an inositol
(1,4,5) triphosphate-triggered release of Ca2+ from the ER
stores and its accumulation in the mitochondrial matrix. In
Afg3l22/2 cells, the mitochondrial Ca2+ peak response
([Ca2+]m) elicited by bradykinin stimulation (50.71+
7.54 mM) was strongly reduced compared with Afg3l2+/2
(74.47+ 7.95 mM, P, 0.001) and wild-type cells (82.87+
10.79 mM, P, 0.001), as measured by the low-affinity
mtAEQmut probe (Fig. 1A). The decreased mitochondrial
Ca2+ response in Afg3l22/2 cells was specific of mitochondria
and not secondary to global cellular Ca2+ signalling. In fact,
cytosolic Ca2+ response ([Ca2+]c) measured by the cytAEQ
probe after bradykinin stimulation revealed no alterations in
Afg3l22/2 cells (1.52+ 0.13 mM) compared with wild-type
cells (1.52+ 0.2 mM) (Fig. 1B). Afg3l2+/2 cells showed a
decreased [Ca2+]c trend (1.35+ 0.2 mM) that may explain
the reduction in [Ca2+]m (Fig. 1A).
We then verified whether the reduction in [Ca2+]m in
Afg3l22/2 cells was dependent on ER as Ca2+ source. We
therefore induced capacitative Ca2+ entry to raise
intracellular-free Ca2+ (24). We treated cells with thapsigar-
gin, an irreversible inhibitor of the sarcoplasmic reticulum
Ca2+ATPase (SERCA pump), in the absence of extracellular
Ca2+ to deplete ER stores and to activate store-operated
Ca2+ channels at the plasma membrane. The re-addition of
1 mM Ca2+ resulted in comparable [Ca2+]m responses in the
three genotypes (1.65+ 0.39 mM in the wild-type; 1.95+
0.43 in heterozygous and 1.74+ 0.45 in Afg3l22/2 cells)
(Fig. 1C). These experiments demonstrate that Afg3l2 null
mitochondria show decreased average [Ca2+]m elevations in
the presence of a maximal Ca2+stimulation, as at the mouth
of IP3 receptor channels (Fig. 1C).
Latent mitochondrial dysfunction of Afg3l22/2 MEFs
in the presence of unaltered Ca21 uptake speed
and basal Dcm
We next examined whether mitochondria of Afg3l22/2 cells
have an intrinsic defect in Ca2+ accumulation by measuring
mitochondrial Ca2+ uptake in digitonin-permeabilized cells
and by imposing an ethylene glycol tetraacetic acid (EGTA)-
buffered Ca2+ concentration of 2 mM (see Materials and
Methods). In these conditions, all mitochondria are allowed
to take up Ca2+ independently of their proximity to the
Ca2+ source. The Ca2+ uptake speed, estimated by linear re-
gression from the slope of the ascending phase of [Ca2+]m
rise (see Materials and Methods), was unchanged in
Afg3l22/2 cells compared with syngenic controls (Fig. 2A).
These data indicate that individual mitochondria lacking
AFG3L2 have intact ability to internalize Ca2+, meaning
that the uptake machinery is likely not altered. We then direct-
ly verified the mRNA and protein levels of the mitochondrial
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Ca2+ uniporter (MCU) and of its regulator mitochondrial
calcium uptake 1 (MICU1). Real-time qPCR revealed compar-
able levels of both transcripts in the three genotypes. Accord-
ingly, western blot showed unchanged protein levels of MCU
and MICU1 in Afg3l22/2 cells compared with controls
(Fig. 2B).
Since mitochondrial Ca2+ uptake is dependent on Dcm and
we previously reported respiratory defects in neuronal tissues
from Afg3l2 knockout and haploinsufficient mouse models
(5,14), we tested whether the defective mitochondrial Ca2+
loading of Afg3l22/2 cells could be secondary to altered mem-
brane polarization. The measurement of Dcm by the evaluation
Figure 1. Loss of Afg3l2 reduces mitochondrial Ca2+ uptake. (A and B) [Ca2+]m and [Ca
2+]c in Afg3l2 MEFs of the indicated genotypes measured by aequorin
probes (mtAEQmut and cytAEQ). On the left: representative graphs; on the right: means+SD of [Ca2+]m and [Ca
2+]c peak responses after bradykinin stimu-
lation, respectively (16 traces obtained from four independent experiments). Student’s t-test: ∗∗P, 0.001, ∗P , 0.05. (C) Measurement of [Ca2+]m (mtAEQ)
after capacitative Ca2+ influx. On the left: representative graph; on the right: means+SD of mitochondrial peak Ca2+ responses (10–12 traces obtained from
four independent experiments).
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of the steady-state loading of the potentiometric dye tetramethyl
rhodamine methyl ester (TMRM) into mitochondria of
Afg3l22/2, Afg3l2+/2 and wild-type MEFs revealed no differ-
ences in the three genotypes (Fig. 2C). From these data, we con-
clude that the reduced Ca2+ uptake ability of Afg3l22/2 cells is
due neither to defective Ca2+ uptake machinery nor to a reduced
driving force for Ca2+ influx.
Nevertheless, a latent mitochondrial dysfunction of
Afg3l22/2 MEFs could be masked by the ATP synthase oper-
ating in the reverse mode and maintaining Dcm during the
Figure 2. Mitochondrial Ca2+ uptake speed and electrochemical gradient are unaffected in Afg3l22/2 cells. (A) [Ca2+]m in permeabilized MEFs measured by
mtAEQmut. On the left: representative graph; on the right: means+SD of the slope of [Ca2+]m rise-ascending phase (10–12 traces obtained from four inde-
pendent experiments). (B) On the right: quantification (real-time qPCR) of MCU and MICU1 mRNA relative to GAPDH mRNA (wild-type was set to 1). On the
left: MCU and MICU1 immunoblot analysis of total cell extracts from Afg3l2MEFs of the indicated genotypes. Bars represent means+SD of three independent
experiments. (C) Analysis of Dcm by uptake of the potentiometric dye TMRM. TMRM fluorescence intensity in Afg3l2
2/2 MEFs and controls relative to
unloaded cells was measured by cytofluorimetry. Bars represent means+SD of four independent experiments. a.u.: arbitrary units. (D) Real-time imaging
of TMRM fluorescence intensity of Afg3l2+/+, Afg3l2+/2 and Afg3l22/2 MEFs loaded with 20 nM TMRM. Cells were imaged every 60 s and mitochondrial
TMRM fluorescence intensity was calculated as described. Where indicated, 4 mg/ml oligomycin A (OligoA) and 4 mM FCCP were added. Data represent
mean+SE of three independent experiments.
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experiment, a mechanism that has already been described in
the literature (25). To test this hypothesis, we measured Dcm
by real-time imaging of TMRM fluorescence intensity
during incubation of cells with oligomycin A (OligoA),
an inhibitor of mitochondrial F1FO-ATP synthase (25,26).
As expected, addition of OligoA to healthy respiring cells
like wild-type MEFs resulted in hyperpolarization of the
inner membrane. In fact, protons pumped by the respiratory
chain in the intermembrane space cannot cross the
F1FO-ATP synthase and remain in the intermembrane space.
In contrast, OligoA addition resulted in a mild mitochondrial
hyperpolarization of Afg3l2+/2 MEFs and in a slow but pro-
gressive mitochondrial depolarization in Afg3l22/2 cells, indi-
cating that the maintenance of Dcm in Afg3l2
2/2 cells relies
on the reverse activity of the ATP synthase (Fig. 2D).
To exclude that the drop of Dcm was secondary to the in-
duction of the mitochondrial permeability transition (MPT),
which depends on the opening of the permeability transi-
tion pore (PTP) (27), we performed real-time imaging of
TMRM fluorescence pre-incubating the cells with a
known inhibitor of MPT, cyclosporine A (CsA), that
desensitizes the PTP via its mitochondrial receptor cyclo-
philin D (27). The treatment with CsA did not prevent the
Dcm drop that is induced by OligoA in Afg3l2
2/2 MEFs,
demonstrating that MPT is not occurring in these cells
(data not shown).
Altogether, these data indicate that Dcm in Afg3l2
2/2 cells
is not maintained by respiration but rather by a reverse activity
of the F1FO-ATP synthase, which pumps protons from the
matrix to the intermembrane space, thereby consuming ATP.
This mechanism masks the mitochondrial dysfunction in
Afg3l22/2 cells, in line with an impairment of the respiratory
chain activity.
Afg3l22/2 cells show increased mitochondrial
fragmentation
Alterations of mitochondrial shape may account for the ineffi-
cient mitochondrial Ca2+ handling of Afg3l22/2 cells. Indeed,
it has been demonstrated that fragmentation of the mitochon-
drial network impairs mitochondrial Ca2+ uptake by modifying
the spatial pattern of the intra-mitochondrial Ca2+ diffusion
(22,28).
We thus evaluated the effect of the loss of Afg3l2 on the
regulation of mitochondrial network morphology by perform-
ing live imaging confocal microscopy in cells overexpressing
a mitochondria-targeted yellow fluorescent protein (mt-YFP).
Similarly to what reported by Ehses et al. (29) upon concomi-
tant downregulation of both Afg3l1 and Afg3l2 in MEFs, we
observed a marked alteration in mitochondrial network
morphology in Afg3l22/2 cells. Morphometric analysis
revealed that wild-type and heterozygous MEFs have
Figure 3. Increased mitochondrial fragmentation in Afg3l22/2cells. (A) Representative pictures of mitochondrial morphology in Afg3l2 MEFs transfected with
mt-YFP and visualized by confocal microscopy. (B) Morphometric analysis of mitochondrial morphology in Afg3l2 MEFs. One hundred and fifty randomly
selected cells were analysed in each experiment. Bars represent means+SD of three independent experiments. The Chi-squared test (2 degrees of
freedom): Afg3l22/2 versus either heterozygous or wild-type MEFs ¼ P , 0.001. (C) Immunoblot analysis of total cell extracts from Afg3l2 MEFs (upper
panel) or neuronal tissues of the indicated genotypes (lower panel). The five OPA1 bands are indicated as long (L1 and L2) and short isoforms (S1, S2 and
S3) (30). Hsp60 and tubulin were used to verify equal loading, respectively.
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elongated and interconnected mitochondria. In contrast,
Afg3l22/2 cells showed more than 50% of cells with small,
round-shaped organelles and only 5% of cells with a tubular
mitochondrial network (Fig. 3A and B).
The proper balance of long and short OPA1 isoforms is crit-
ical for maintenance of tubular mitochondrial morphology
(30). MEFs express four alternative splicing mRNAs coding
for OPA1 isoforms, resulting from the inclusion or the exclu-
sion of exons 4b and 5b (31). These isoforms undergo different
proteolytic cleavages (7,30,32) resulting in five bands on
SDS–PAGE, corresponding to long (L1 and L2) and short
(S1 to S3) processed OPA1 isoforms. The analysis of OPA1
band pattern in wild-type, Afg3l2+/2 and Afg3l22/2 cells by
western blotting revealed that the loss of AFG3L2 results in
alteration of OPA1 processing: we detected an increased
amount of short OPA1 forms and the almost-complete dis-
appearance of the long bands in Afg3l22/2 MEFs (Fig. 3C).
No apparent differences were observed between Afg3l2 wild-
type and heterozygous cells, indicating that AFG3L2 haploin-
sufficiency does not affect OPA1 processing and mitochon-
drial morphology in this cellular system (Fig. 3A–C).
Mitochondrial fragmentation in Afg3l22/2 MEFs is rescued
by the overexpression of wild-type AFG3L2, but this effect
is not achieved with the overexpression of AFG3L2M666R,
one of the most severe SCA28-causing mutations (10) (Sup-
plementary Material, Fig. S1A).
We also evaluated OPA1 processing in the neuronal tissues
of Afg3l22/2 mice, in particular in the brain, cerebellum and
spinal cord, which are the most affected by Afg3l2 loss and
also by AFG3L2 mutations (5,10,12). As shown in the
western blot in Figure 3C, OPA1 processing is increased in
Afg3l22/2 mouse neuronal tissues, thus confirming the
pathogenetic relevance of mitochondrial fragmentation in
AFG3L2-associated diseases.
Fission of the mitochondrial network reduces organellar
matrix continuity and leaves a fraction of mitochondria
devoid of connection to the ER
We evaluated whether the mitochondrial fragmentation
observed in Afg3l22/2 cells could impact on the number of
mitochondria/ER contacts, specialized sites where IP3R/RyR-
mediated Ca2+ oscillations are propagated locally to the mito-
chondria. The close vicinity of mitochondria to Ca2+-release
sites on the ER is crucial for the activation of the MCU and
thus for the rapid and efficient accumulation of Ca2+ inside
the organelles (33,34). To measure the total number of con-
tacts in the whole cell volume, we analysed the colocalization
between mitochondria and ER with three-dimensional (3D) re-
construction and volume rendering of confocal stacks of
ER-targeted green fluorescent protein (ER-GFP) and
mitochondrial-targeted red fluorescent protein (mt-RFP) in
the three genotypes, as previously reported (22,35)
(Fig. 4A). In this analysis, we considered the overlapping
mitochondrial and ER spots as the sites where most-efficient
Ca2+ transfer between the two organelles occurs, thus satisfy-
ing the high Ca2+ concentration demand for the opening of the
MCU. As measured by Manders’ colocalization coefficient
(36), we found that the evident fragmentation of the
mitochondrial network does not affect the average number
of mitochondria-ER contact sites in Afg3l22/2 cells (Fig. 4B).
Similarly, the overall volume of the organellar network of
both mitochondria and ER is unaffected by the loss of
AFG3L2, as demonstrated by quantitative morphological
imaging of the mitochondrial and ER networks by transfecting
cells with mt-RFP or ER-GFP, respectively. After 3D recon-
struction of confocal stacks, the images were analysed evalu-
ating the total volume of the organellar network. ER
architecture was unaffected by the loss of Afg3l2, appearing
as an interconnected network of cistarnae spanning the
whole cellular volume. We also observed that fragmentation
of the mitochondrial network does not alter either the mito-
chondrial or the ER total volume, the ratio of the two organel-
lar volumes being comparable in the three genotypes
(Fig. 4C). According to the observed fragmentation, we
found a significant reduction in the average size of individual
mitochondrial particle in Afg3l22/2cells compared with con-
trols (6.94+ 2.3 versus 12.68+ 3.35 mm3 in wild-type
and 12.3+ 1.91 mm3 in heterozygous cells, P , 0.001)
(Fig. 4C). Having the three cell lines the same mitochondrial
total volume, these data indicate that Afg3l22/2 cells have
an increased number of individual mitochondria compared to
wild-type and heterozygous cells. This hypothesis was verified
by counting the total number of RFP-positive objects per cell,
which is almost doubled in Afg3l22/2 cells compared with
control cells, while the percentage of objects that are in
contact with the ER is reduced (Fig. 4D). These data demon-
strate that a significant number of Afg3l2 null mitochondria
lacks connections to the ER, and thus to Ca2+ sources, and
therefore remains without significant [Ca2+]m rises.
Rescue of mitochondrial fragmentation by OPA1 and
MFN1 overexpression restores normal mitochondrial Ca21
uptake in Afg3l22/2 cells
To validate our hypothesis, we decided to investigate whether
rescue of mitochondrial fragmentation could ameliorate mito-
chondrial Ca2+ uptake in Afg3l22/2 cells. For this purpose, we
generated wild-type, heterozygous and knockout MEF lines
stably expressing wild-type OPA1 isoform1 (OPA1v1) or a
mutant version of OPA isoform1 carrying a mutation within
the GTP-binding domain (OPA1v1Q297V). By mimicking
the GTP-bound form of OPA1, this mutant has been described
as constitutively active and disassembly resistant form (37). In
order to avoid strong overexpression of OPA1, being known
that this can cause clustering of small mitochondria (38),
we transfected cells with pMSCV-OPA1v1 or pMSCV-
OPA1v1Q297V constructs, where OPA1 cDNA expression is
under the control of the weak murine stem cell virus promoter.
As already reported by other groups in transient transfection
experiments (37), the expression levels of exogenous OPA1v1
and OPA1v1Q297V revealed by western blot analysis were
modest. We indeed detected a slight increase in the expected
second (L2) and fifth bands (S3) in cells expressing OPA1v1
and OPA1v1Q297V compared with those transfected with
the empty vector (EV) (Supplementary Material, Fig. S2B).
Nevertheless, we observed that the moderate overexpression
of OPA1v1 and OPA1v1Q297V clearly affects mitochondrial
morphology in stable cell lines. In fact, morphometric analysis
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revealed that .50% of the Afg3l22/2::EV analysed cells dis-
played fragmented mitochondria, exactly like immortalized
Afg3l22/2 MEFS. This percentage is strikingly reduced in
Afg3l22/2::OPA1v1 cells, where most mitochondria appear
in the intermediate state. The effect is even more evident in
Afg3l22/2::OPA1v1Q297V MEFs, in which tubulated mito-
chondria are the most represented (Fig. 5A). Accordingly,
imaging of Afg3l2+/2::OPA1v1 cells revealed an increased
percentage of tubular mitochondria compared with
Afg3l2+/2::EV cells. In Afg3l2+/2::OPA1v1Q297V, most of
the organelles are highly elongated and interconnected in a
branched network (Supplementary Material, Fig. S3A and
B). These findings indicate that the modest restoration of
OPA1 L2 band is able to rescue mitochondrial fragmentation
in Afg3l22/2cells and to increase the fusion rate in Afg3l2+/2
cells.
Figure 4.Mitochondrial fragmentation leaves a fraction of organelles free of connections to the ER. (A) Representative images of Afg3l2 knockout, heterozygous
and wild-type MEFs cotransfected with ER-GFP and mt-RFP. Insets show 3D reconstructed confocal stacks. (B) Quantitative analysis of ER-mitochondria colo-
calization estimated by Manders’ coefficient. (C) Effect of Afg3l2 depletion on total mitochondrial volume and on individual mitochondrial particles, respect-
ively. (D) Quantification of the total number of RFP-positive objects and quantification of the percentage of RFP-positive objects in contact with the ER in the
three genotypes. Data were obtained from an average of 60 randomly selected cells per genotype. Bars represent means+SD of three independent experiments.
Student’s t-test: ∗P , 0.05, ∗∗P , 0.001.
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Figure 5. The defective mitochondrial Ca2+ uptake is rescued by OPA1 or MFN1 overexpression. (A) Morphometric analysis of mitochondrial morphology of
Afg3l22/2 cells stably expressing wild-type OPA1v1 or OPA1v1-Q297V. One hundred and fifty randomly selected cells were analysed in each experiment.
Bars represent means+SD of three independent experiments. EV, empty vector. The Chi-squared test (2 degrees of freedom): Afg3l22/2::EV MEFs versus
either ::OPA1v1 or ::OPA1v1Q297V ¼ P, 0.001, ::OPA1v1 versus ::OPA1v1Q297V ¼ P, 0.001. (B) [Ca2+]m measured by aequorin probes (mitAEQmut)
of Afg3l22/2 cells stably expressing wt OPA1v1 or OPA1v1-Q297V. On the left: representative graphs; on the right: means+SD of [Ca2+]m peak responses
after bradykinin stimulation (12 traces obtained from four independent experiments). Student’s t-test: ∗∗P, 0.001, ∗P, 0.05. (C) Real-time imaging of
TMRM fluorescence intensity of Afg3l2+/2 and Afg3l22/2 cells stably expressing wt OPA1v1 or OPA1v1-Q297V loaded with 20 nM TMRM. Cells were
imaged every 60 s and mitochondrial TMRM fluorescence intensity was calculated as described. Where indicated, 4 mg/ml oligomycin A (OligoA) and 4 mM
FCCP were added. Data represent mean+SE of five independent experiments. (D) Morphometric analysis of mitochondrial morphology of Afg3l22/2 overexpres-
sing MFN1. One hundred and fifty randomly selected cells were analysed in each experiment. Bars represent means+SD of three independent experiments. The
Chi-squared test (2 degrees of freedom): Afg3l22/2::EV MEFs versus either ::MFN1 or Afg3l2+/2::EV¼ P, 0.001, Afg3l2+/2::EV versus Afg3l22/2::MFN1¼
P, 0.001. (E) [Ca2+]m measured by aequorin probes (mitAEQmut) of Afg3l2
2/2 cells transfected with MFN1. On the left: representative graphs; on the right:
means+SD of [Ca2+]m peak responses after bradykinin stimulation (10 traces obtained from two independent experiments). Student’s t-test: ∗∗P, 0.001.
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We next examined whether the rescue of mitochondrial
morphology could ameliorate the defective Ca2+ handling
capacity of Afg3l22/2 cells. We thus measured mitochondrial
Ca2+ uptake in stable cell lines using the mitochondria-
targeted aequorin mtAEQmut. Bradykinin stimulation of
Afg3l22/2::EV MEFs resulted in [Ca2+]m rises similar to
those measured in Afg3l22/2 MEFs (51.46+ 10.48 mM). On
the contrary, OPA1v1 overexpressing cells showed a signifi-
cant increase in the bradykinin-evoked [Ca2+]m rise (66.7+
4.4 mM, P, 0.05), that was greater in OPA1v1Q297V overex-
pressing cells (76.1+ 9.1 mM, P, 0.001) (Fig. 5B).
To verify that the rescue of the defective Ca2+ uptake in
Afg3l22/2::OPA1v1 and Afg3l22/2::OPA1v1Q297V was spe-
cifically caused by the recovery of mitochondrial morphology
and not by a different effect of OPA1 overexpression in the
inner membrane, we tested whether it can be achieved by
stimulating mitochondrial fusion through a different molecular
system. Namely, we assessed mitochondrial morphology in
Afg3l22/2 cells after overexpression of MFN1, essential for
outer membrane fusion (39), and we observed a significant re-
duction in the amount of cells harbouring fragmented orga-
nelles and an increased quote of cells harbouring fused
organelles (Fig. 5D). Of note, we found that MFN1 overex-
pression is able to increase bradykinin-evoked [Ca2+]m rise
in Afg3l22/2 MEFs (68.61+ 4.3 mM, P , 0.001) compared
with mock-transfected cells (55.49+ 9.18 mM) (Fig. 5E).
These data prove that Afg3l22/2 cells are still fusion compe-
tent and clearly demonstrate that the defective ability of
Afg3l22/2 cells to internalize Ca2+ is dependent on fragmen-
tation of the mitochondrial network (Fig. 6).
Since stable expression of OPA1v1 or OPA1v1-Q297V
rescued the mitochondrial network fragmentation in
Afg3l22/2 MEFs, we then examined whether OPA1 can
rescue also the progressive mitochondrial depolarization of
OligoA-treated Afg3l22/2 MEFs. The real-time imaging of
TMRM in these stable cell lines exposed to OligoA showed
no recovery of the Dcm in Afg3l2
2/2 cells stably expressing
wild-type OPA1v1 or OPA1v1-Q297V to levels comparable
to the control cells (Fig. 5C). Therefore, we conclude that
the rescue of mitochondrial network morphology by OPA1
is not sufficient to recover the latent mitochondrial dysfunction
of Afg3l22/2 cells.
DISCUSSION
In this study, we evaluated the mitochondrial Ca2+ uptake cap-
acity of Afg3l2-depleted cells. Our results show that the loss of
Afg3l2 causes a marked reduction in mitochondrial Ca2+ buf-
fering. This defect depends neither on impaired organellar
Ca2+ uptake machinery nor on alteration of Dcm, since
MCU mRNA and protein levels and TMRM loading resulted
comparable between mutant and controls. These observations
are in line with the fact that Afg3l22/2 individual mitochon-
dria present intact ability to accumulate Ca2+, as demonstrated
by unchanged Ca2+ uptake speed in digitonin-permeabilized
cells experiments. We showed that the defective Ca2+
uptake of Afg3l22/2 cells is instead caused by fragmentation
of the mitochondrial network, secondary to enhanced process-
ing of OPA1. Evidence for this mechanism is provided by
rescue experiments, where we stably expressed wild-type
OPA1v1 or a constitutively active form of OPA1
(OPA1v1-Q297V) in Afg3l22/2 MEFs. By slightly increasing
the amount of the long OPA1 isoforms (L2 band) that promote
organellar fusion, the overexpression of OPA1v1 is able to
recover fragmentation of the mitochondrial network in
Afg3l22/2 cells. This effect is even more pronounced with
OPA1v1-Q297V overexpression, which increases the number
of cells with a tubular network, besides reducing mitochon-
drial fragmentation. This can be explained by the fact that
Q297V mutation, as previously proposed (37,40), should
make OPA1 constitutively active by mimicking the
GTP-bound state. Notably, we showed that fusion restoration
in Afg3l22/2::OPA1v1 MEFs significantly ameliorates mito-
chondrial Ca2+ buffering respect to Afg3l22/2::EV cells and
that the defect is completely recovered in Afg3l22/2::
OPA1v1Q297V MEFs. We also demonstrated that overexpres-
sion of MFN1, an outer membrane regulator of mitochondrial
fusion, exerts the same effect of OPA1v1 on both mitochon-
drial morphology and Ca2+ buffering in Afg3l22/2 MEFs.
Figure 6.Model explaining the defective Ca2+ buffering in Afg3l22/2 cells. The red dots represent ER-mitochondria Ca2+ transmission sites. In Afg3l22/2 cells,
many mitochondria remain without contacts with ER, and thus without Ca2+ elevations. The Ca2+ ions reaching mitochondria propagate less efficiently in a
fragmented organellar network compared with a tubular one.
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These findings prove that mitochondrial fusion can occur in
the absence of AFG3L2 and can be enhanced by overexpres-
sing mitochondrial fusion regulators. In addition, since
MFN1 can efficiently tubulate mitochondria in the presence
of OPA1 (38), they indicate that the overall amount of long
and short OPA1 isoforms present in Afg3l2-depleted cells is
sufficient to respond to fusion induction triggered by MFN1.
Moreover, these data demonstrate that impaired Ca2+ buffer-
ing in the absence of AFG3L2 is indeed caused by mitochon-
drial fragmentation secondary to enhanced OPA1 processing.
The mechanism through which the loss of AFG3L2 induces
increased processing of OPA1 is not fully understood. OMA1,
a metallopeptidase of the inner mitochondrial membrane,
mediates the cleavage of OPA1 in the absence of AFG3L2
(29). Moreover, the loss of Dcm or decreased ATP levels is
known to augment OPA1 processing (41,42). Whether
OMA1 is directly regulated by AFG3L2 itself or indirectly
by the respiratory deficiencies mediated by the loss of
AFG3L2 (5) remains to be determined. Here, we provide evi-
dence that respiratory dysfunction is the primary defect fol-
lowing AFG3L2 depletion and associates to mitochondrial
fragmentation.
In fact, our studies on the regulation of Dcm in the absence
of AFG3L2 in MEFs show that Dcm in basal conditions is not
altered. On the other hand, treatment with the ATP-synthase
inhibitor Oligo A revealed depolarization in Afg3l22/2 cells,
indicating that Dcm is maintained through the reverse activity
of the F1FO-ATP synthase and not by respiration. This pheno-
type is in line with a dysfunction in the activity of the respira-
tory chain complexes, which affects proton pumping across
the inner mitochondrial membrane and requires reversion of
the activity of ATP synthase (i.e. consuming ATP) for
proton pumping from the matrix to the intermembrane space
to achieve the maintenance of Dcm. As a direct consequence,
the inhibition of the ATP synthase activity by Oligo A pro-
duces a decline of Dcm, as observed in Afg3l2 knockout
MEFs. Interestingly, stable expression of OPA1v1 or
OPA1v1-Q297V is not able to rescue the progressive mito-
chondrial depolarization of OligoA-treated Afg3l22/2 MEFs
to levels comparable with the wild-type demonstrating that
the rescue of mitochondrial network morphology is not suffi-
cient to recover the latent mitochondrial dysfunction. These
data indicate that the impaired mitochondrial respiration is
the primary defect following depletion of Afg3l2 that we hy-
pothesize is the cause of the increase in OPA1 processing
and of the following mitochondrial fragmentation.
This is in line with the fact that in Afg3l2+/2 MEFs, OligoA
addition resulted in a milder hyperpolarization compared with
wild-type cells. This can indicate a reduced efficiency of mito-
chondrial respiration in Afg3l2+/2 cells, although mitochon-
drial morphology and OPA1 processing are not affected in
this cellular system.
All this considered, we demonstrate the consequential ar-
rangement of events, starting from loss of AFG3L2, to respira-
tory dysfunction, OPA1 cleavage and finally to organellar
fragmentation, although some mechanistic steps of this
process are indeed still lacking and maybe include some
new effectors still to be identified.
We observed that mitochondrial fragmentation in
Afg3l22/2 cells reduces the volume of individual
mitochondrial particles without changing the total volume of
the organellar network. As a direct consequence, a fraction
of mitochondria in Afg3l22/2cells lose their link to the ER
and result positioned at a higher distance from the Ca2+
source, failing to match the MCU-activation needs (33) and
therefore remaining without substantial [Ca2+]m rises. More-
over, studies have shown that Ca2+ entering mitochondria
can spread and equilibrate rapidly within the matrix along
large and tubular, but not fragmented organelles. In fact, the
small size of mitochondrial particles in a fragmented
network and the consequent lack of matrix connectivity limit
the proper diffusion of the Ca2+ wave and increases the het-
erogeneity of mitochondrial Ca2+ responses (22,28). Together,
these phenomena account for the overall reduction in the mito-
chondrial Ca2+ load in Afg3l22/2 cells.
Heterozygous and homozygous mutations in AFG3L2 cause
neurodegeneration that involves PCs in the cerebellum and
results in ataxia (9,12). The fact that cerebellum is more sen-
sitive to AFG3L2 dysfunction compared with other neuronal
tissues can be explained by the high expression of this gene
in PCs (9), but also with the special requirement of mitochon-
drial functionality by PCs. These are indeed unique neurons
with very large and highly branched dendritic trees that
receive only excitatory inputs. They are therefore exposed to
high Ca2+ influxes due to glutamatergic stimulation of both
mGluR1 and AMPA receptors (19). For these reasons, mito-
chondria play a pivotal role in maintaining Ca2+ homeostasis
in PCs by direct uptake of Ca2+ and, also, by providing ATP
to pump Ca2+ across membranes.
We therefore hypothesize that the inefficient buffering and
shaping of the Ca2+ waves operated by mutant mitochondria
provokes a local increase in [Ca2+]c and that this, in chronic
conditions like as in AFG3L2-associated diseases, triggers
PCs degeneration.
Considering what mentioned above, it is conceivable that
Afg3l2 haploinsufficiency causes inefficient Ca2+ buffering
in PCs in a progressive degenerative situation. Nonetheless,
we failed to demonstrate mitochondrial fragmentation and de-
fective Ca2+ uptake in Afg3l2+/2 fibroblasts likely because in
culture they rely marginally on mitochondria for ATP produc-
tion and Ca2+ buffering compared with neurons and, also,
because in these cells the Ca2+ wave could only be elicited
by ER stimulation. Moreover, we performed acute experi-
ments that do not properly mimic the physio-pathological con-
dition of chronic degeneration.
We can hypothesize that fragmentation of the mitochondrial
network in Afg3l2-depleted PCs causes defective mitochon-
drial Ca2+ buffering, but also inefficient trafficking of the
organelles to dendritic stalks and distal branches. Indeed, it
has been demonstrated that in PCs lacking mitochondrial
fusion, both increased mitochondrial diameter due to swelling
and aggregations of mitochondria seem to block efficient entry
into neurites, resulting in a dearth of mitochondria in axons
and dendrites (43). In the worst scenario, the two events
may negatively synergize causing not only the inefficient op-
position to Ca2+wave close to the ER and at in dendrites, but
the increased mitochondria retention in the cell soma, too.
In conclusion, our results functionally link for the first time
AFG3L2 to mitochondrial Ca2+ buffering. The molecular
pathogenesis of SCA28 can now be drawn in the light of the
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inefficient mitochondrial Ca2+ uptake as one of the triggering
events of PC-DCD.
MATERIALS AND METHODS
MEF lines
Primary MEFs were established from embryonic day E16.5
from Afg3l2 knockout, heterozygous and wild-type embryos
(5) and immortalized by SV40 (44), using 300 mg/ml geneticin
for selection.
For the generation of stable cell lines, MEFS were
transfected with pMSCV-EV, pMSCV-OPA1v1 and pMSCV-
OPA1v1Q297V constructs and selected with 1 mg/ml puro-
mycin for 2 weeks. Transfection was performed using
Metafectene (Biontex Laboratories, San Diego, CA, USA)
according to the manufacturer’s instruction.
Aequorin measurements
MEFs grown on 13 mM round glass cover slips at 50% conflu-
ence were transfected with the cytosolic (cytAEQ) or mito-
chondrial aequorin probes (mtAEQmut or mtAEQ). Cells
were reconstituted with 5 mM coelenterazine for 90 min in
DMEM supplemented with 1% fetal bovine serum, incubated
in KRB (Krebs–Ring modified buffer: 125 mM NaCl, 5 mM
KCl, 1 mM Na3PO4, 1 mM MgSO4, 5.5 mM glucose, 20 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
pH 7.4, 378C) supplemented with 1 mM CaCl2 and then trans-
ferred to the perfusion chamber. When indicated, 100 nM
bradykinin was added. The experiments were concluded by
lysing MEFs with 100 mM digitonin in a hypotonic
Ca2+-rich solution (10 mM CaCl2 in H2O), thus discharging
the remaining aequorin pool. The light signal was collected
in a purpose-built luminometer as previously described (23).
[Ca2+]mt following capacitative Ca
2+ influx was measured
by perfusing MEFs with the SERCA inhibitor thapsigargin
(1 mM) in a KRB solution containing no Ca2+ and 100 mM
EGTA. Mitochondrial Ca2+ uptake was evoked by adding
1 mM CaCl2 to the medium and was measured by mtAEQ.
In the experiments with permeabilized cells, a buffer mim-
icking the cytosolic Ca2+ ionic composition (intracellular
buffer) was used: 130 mM KCl, 10 mM NaCl, 2 mM K2HPO4,
5 mM succinic acid, 5 mM malic acid, 1 mM MgCl2, 20 mM
HEPES, 1 mM pyruvate, 0.5 mM ATP and 0.1 mM ADP
(378C, pH 7). Intracellular buffer was supplemented with
either 100 mM EGTA (intracellular buffer/EGTA) or a 2 mM
EGTA and 2 mM hydroxy-2-ethylenediaminetriacetic acid-
buffered [Ca2+] of 2 mM (intracellular buffer/Ca2+) calculated
with the Chelator software (45).
RNA extraction and gene expression analysis
Total RNA from cells was purified using Trizol (Invitrogen,
Carlsbad, CA, USA) following the manufacturer’s instructions.
cDNAwas generated using aThermo script RT–PCR systemkit
(Invitrogen). For the expression of MCU and MICU1, cDNA
was analysed by real-time PCRusing the SYBRgreen chemistry
(Light cycler 480, SYBR green I master, Roche, Basel,
Switzerland). MCU and MICU1-PCR-primer sequences were
previously described by De Stefani et al. (20). glyceraldehyde
3-phosphate dehydrogenase was used for normalization.
Western blot analysis
OPA1 band pattern was analysed by standard western blot pro-
cedure. Total cell lysate was prepared by protein extraction
using a Triton-containing buffer (10 mM Tris–HCl, pH 7.4,
150 mM NaCl, 1% Triton, 1 mM ethylenediaminetetraacetic
acid (EDTA) pH 8, 1X Protease Inhibitor Cocktail, Roche,
Basel, Switzerland). Twenty micrograms of protein extracts
were dissolved in sample buffer (60 mM Tris–HCl, pH 6.8,
5% glycerol, 1.7% SDS, 0.1 M DTT, 0.002% bromophenol
blue), were separated on 7% SDS–PAGE and analysed by
standard immunoblotting procedures. Anti-OPA1 antibody was
from BD Transduction Laboratories (Franklin Lakes, NJ,
USA), anti-Hsp60 and Hsp70 antibodies were from Stressgen
(San Diego, CA, USA). For the detection of MCU and MICU1,
cells were lysed with radio immunoprecipitation assay buffer
(NaCl 150 mM, Tris–HCl 50 mM, EDTA 1 mM, pH 8, NP40
1%, SDS 0.1%, Sodium Deoxycholate 1%). Fifty micrograms
of protein extracts were dissolved in sample buffer and loaded
on a 7% SDS–PAGE followed by immunoblotting. Anti-MCU
(CCDC109A) and anti-MICU1 antibodies were from SIGMA
(St Louis, Missouri, USA), anti-tubulin was from Invitrogen.
Measurements of mitochondrial membrane potential
DCm was measured using the mitochondrial potentiometric
dye TMRM (Invitrogen) and analysing cells uptake of the
compound cytofluorimetrically. Cells were seeded in
six-well multi-dishes, 300 000 cells/well. Twenty-four hours
after plating, cells were collected, washed in PBS 1× and
then suspended in phenol-red free Hank’s buffered salt solu-
tion (HBSS) 1× supplemented with 10 mM HEPES, 2 mM
Ciclosporin H (Alexis Biochemicals, San Diego, CA, USA)
and 20 nM TMRM and incubated for 30 min at 378C. In paral-
lel, after incubation with TMRM containing medium, cells
were treated for 5 min with 4 mM trifluorocarbonylcyanide
phenylhydrazone (FCCP), as control of specific mitochondrial
staining. TMRM fluorescence was analysed using Cytomics
FC500 Flow Cytometry System (Beckman Coulter). Output
files were analysed using flow cytometry data analysis
program WinMDI 2.8.
Real-time analysis of Dcm was performed as follows.
Afg3l2+/+, Afg3l2+/2 and Afg3l22/2 MEFs were plated in
12-well multi-dishes, 50 000 cells/well. After 40 h, cells
were incubated with 20 nM TMRM, 2 mM CsH and 2 mg/ml
Hoechst 33 342 dissolved in phenol-red free HBSS 1× supple-
mented with 10 mM HEPES for 30 min at 378C. For CsA pre-
treatment, cells were incubated for 30 min at 378C in the
abovementioned medium supplemented with 2 mM CsA.
Images were acquired with IN Cell Analyzer 1000 (GE
Healthcare, Little Chalfont, UK). Sequential images of
TMRM fluorescence from at least three regions of interest
(ROIs) were acquired every 60 s. Four micrograms per milli-
litre oligomycin A and 4 mM FCCP were added in each well,
after minute 5 and minute 55 of the acquisition, respectively,
by In Cell Analyzer motorized injector. Images were stored for
subsequent analysis using IN Cell Investigator software. Five
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independent experiments were performed. The average
TMRM fluorescence intensity of at least 15 ROIs minus back-
ground was calculated for each frame and normalized for com-
parative purposes.
Imaging analyses
Analysis of mitochondrial network morphology was per-
formed as described (38) by expressing a mt-YFP (Clontech,
Mountain View, CA, USA) and live imaging confocal micros-
copy. An average of 150 cells was analysed for each experi-
mental condition. Cells were divided into three classes
accordingly to mitochondria shape: tubular mitochondrial
network, intermediate or fragmented mitochondrial structures.
Experiments were repeated at least three times, and
three operators analysed the images, independently. The
Chi-squared test on row data was applied for significance cal-
culation (degrees of freedom ¼ 2).
For the analysis of mitochondrial and ER volumes, cells
were transfected with mitochondrial-targeted red fluorescent
protein mt-RFP (Clontech) and ER-targeted green fluorescent
protein (ER-GFP, kindly provided by R. Sitia) and stacks of
consecutive confocal images taken at 0.1 mm intervals were
acquired. 3D reconstruction and volume rendering were per-
formed using Volocity 3D Image Analysis Software version
5.5.1, Perkin Elmer, Norwalk, MA, USA.
Manders’ coefficient was applied for the quantitative ana-
lysis of mitochondria-ER colocalization. In all the experi-
ments, confocal microscopy was performed using Perkin
Elmer UltraVIEW Spinning Disk Confocal Microscope and
EMCCD Hamamatsu C9100 imaging camera. The system is
equipped with a stage incubator from OkoLab (www.okolab.
com), allowing to work with live cells maintained under
stable conditions of temperature, CO2 and humidity.
For each cell, the total number of red objects (mitochondria)
was identified using the IN Cell Developer Toolbox 1.8 (GE
Healthcare). After the optimization of segmentation para-
meters, a mask was created to cover the mitochondrial
network. This mask was projected on the ER. At this point,
a threshold was set in order to classify mitochondria using
the green (ER) intensity. Mitochondria with a green signal in-
tensity greater than or equal to the threshold were classified as
in contact with the ER, whereas mitochondria with a green
signal intensity less than threshold were classified as free of
contacts.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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